Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization

Transcriptome analyses of the cortex and white matter of focal cortical dysplasia type II: Insights into pathophysiology and tissue characterization

IntroductionFocal cortical dysplasia (FCD) is a common cause of pharmacoresistant epilepsy. According to the 2022 International League Against Epilepsy classification, FCD type II is characterized by dysmorphic neurons (IIa and IIb) and may be associated with balloon cells (IIb). We present a multic...

Full description

Bibliographic Details
Main Authors:	Guilherme Rossi Assis-Mendonça, Maria Carolina Pedro Athié, João Vitor Gerdulli Tamanini, Arethusa de Souza, Gabriel Gerardini Zanetti, Patrícia Aline Oliveira Ribeiro de Aguiar Araújo, Enrico Ghizoni, Helder Tedeschi, Marina Koutsodontis Machado Alvim, Vanessa Simão de Almeida, Welliton de Souza, Roland Coras, Clarissa Lin Yasuda, Ingmar Blümcke, André Schwambach Vieira, Fernando Cendes, Iscia Lopes-Cendes, Fabio Rogerio
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Neurology
Subjects:	focal cortical dysplasia transcriptome cholesterol biosynthesis enzymes humanin-like 12 GPNMB molecular biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1023950/full

Similar Items

HPexome: An automated tool for processing whole-exome sequencing data
by: Lucas L. Cendes, et al.
Published: (2020-01-01)

Rqc: A Bioconductor Package for Quality Control of High-Throughput Sequencing Data
by: Wélliton de Souza, et al.
Published: (2018-11-01)

Identifying cellular markers of focal cortical dysplasia type II with cell-type deconvolution and single-cell signatures
by: Isabella C. Galvão, et al.
Published: (2023-08-01)

A genética das epilepsias The genetics of epilepsies
by: Iscia Lopes-Cendes
Published: (2008-08-01)

Benchmarking the proteomic profile of animal models of mesial temporal epilepsy
by: Amanda M. Canto, et al.
Published: (2022-04-01)

A review of ancestrality and admixture in Latin America and the caribbean focusing on native American and African descendant populations
by: Thais C. De Oliveira, et al.
Published: (2023-01-01)

Multidimensional Approach Assessing the Role of Interleukin 1 Beta in Mesial Temporal Lobe Epilepsy
by: Renato O. Santos, et al.
Published: (2021-08-01)

The Relationship Between Depression and Anxiety Symptoms of Adult PWE and Caregivers in a Tertiary Center
by: Rafael Batista João, et al.
Published: (2022-03-01)

Automated Online Quantification Method for 18F-FDG Positron Emission Tomography/CT Improves Detection of the Epileptogenic Zone in Patients with Pharmacoresistant Epilepsy
by: Vanessa Cristina Mendes Coelho, et al.
Published: (2017-09-01)

A Prediction Algorithm for Drug Response in Patients with Mesial Temporal Lobe Epilepsy Based on Clinical and Genetic Information.
by: Mariana S Silva-Alves, et al.
Published: (2017-01-01)

Pharmacogenetics: reality or fiction? Or are we there yet?
by: Iscia Lopes-Cendes, et al.
Published: (2011-04-01)

Clinical presentation of juvenile Huntington disease
by: Ruocco Heloísa H., et al.
Published: (2006-01-01)

The transcriptome of rat hippocampal subfields
by: João P.D. Machado, et al.
Published: (2022-12-01)

Primary sarcoma of the leptomeninges: unusual presentation and previously undescribed neuroimaging features
by: João Vitor Gerdulli Tamanini, et al.

Circulating Metabolites as Biomarkers of Disease in Patients with Mesial Temporal Lobe Epilepsy
by: Alexandre B. Godoi, et al.
Published: (2022-05-01)

Methodological differences can affect sequencing depth with a possible impact on the accuracy of genetic diagnosis
by: Murilo G. Borges, et al.
Published: (2020-04-01)

The new world of RNAs
by: Danyella Barbosa Dogini, et al.
Published: (2014-01-01)

Intermittent perilesional edema and contrast enhancement in epilepsy with calcified neurocysticercosis may help to identify the seizure focus
by: Job Monteiro C. Jama‐António, et al.
Published: (2019-06-01)

Neurocysticercosis and Hippocampal Atrophy: MRI Findings and the Evolution of Viable or Calcified Cysts in Patients With Neurocysticercosis
by: Job Monteiro C. Jama-António, et al.
Published: (2019-04-01)

Linkage study of voltage-gated potassium channels in familial mesial temporal lobe epilepsy Análise de ligação dos canais de potássio voltagem-dependente na epilepsia de lobo temporal mesial familiar
by: Cláudia Vianna Maurer-Morelli, et al.
Published: (2007-03-01)

Cyclooxygenase-1 as a potential therapeutic target for seizure suppression: evidences from zebrafish pentylenetetrazole-seizure model
by: Patricia Gonçalves Barbalho, et al.
Published: (2016-11-01)

Laboratorial diagnosis of fragile-X syndrome: experience in a sample of individuals with pervasive developmental disorders Diagnóstico laboratorial da síndrome do cromossomo X frágil: experiência em uma amostra de indivíduos com distúrbios invasivos do desenvolvimento
by: Carlos Eduardo Steiner, et al.
Published: (2005-09-01)

Aspectos genéticos de las epilepsias: una visión actualizada
by: Iscia Lopes-Cendes, M.D., PHD, et al.
Published: (2013-11-01)

Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy
by: Eleonora Borges Gonçalves, et al.
Published: (2018-02-01)

Aspectos genéticos das epilepsias: uma visão atual
by: Iscia Lopes-Cendes, M.D., PH.D., et al.
Published: (2013-11-01)

Strand Analysis, a free online program for the computational identification of the best RNA interference (RNAi) targets based on Gibbs free energy
by: Tiago Campos Pereira, et al.
Published: (2007-01-01)

Case Report: Surgical Treatment of Drug-Resistant Temporal Lobe Epilepsy
by: Fernando Cendes
Published: (2020-12-01)

Analysis of energetically biased transcripts of viruses and transposable elements
by: Rodrigo Secolin, et al.
Published: (2012-01-01)

Molecular diagnosis of Huntington disease in Brazilian patients
by: TEREZA C. LIMA E SILVA, et al.
Published: (2000-03-01)

Epilepsias parciais familiares
by: ELIANE KOBAYASHI, et al.
Published: (2000-09-01)

Comprometimento da Capacidade para o Trabalho e efeitos neuropsicológicos entre trabalhadores com Covid-19 prévia
by: Livia de Pinho Ferreira, et al.
Published: (2023-11-01)

Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders
by: Amanda Donatti, et al.
Published: (2020-09-01)

Level of physical activity and aerobic capacity associate with quality of life in patients with temporal lobe epilepsy.
by: Nathalia Volpato, et al.
Published: (2017-01-01)

Exploratory structural assessment in craniocervical dystonia: Global and differential analyses.
by: Larissa Vilany, et al.
Published: (2017-01-01)

Practices in the prescription of antiseizure medications: is it time to change?
by: Lécio Figueira Pinto, et al.
Published: (2024-06-01)

Amygdala enlargement in patients with mesial temporal lobe epilepsy without hippocampal sclerosis
by: Ana Carolina Coan, et al.
Published: (2013-10-01)

Editorial: Advances and Applications of the EEG-fMRI Technique on Epilepsies
by: Brunno Machado De Campos, et al.
Published: (2022-01-01)

Relação dose-dependente do uso crônico de fenitoína e atrofia cerebelar em pacientes com epilepsia Dose-related cerebellar atrophy in patients with epilepsy using phenytoin
by: ANDRÉ DEL NEGRO, et al.
Published: (2000-06-01)

Multi‐omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy
by: Estela M. Bruxel, et al.
Published: (2022-08-01)

Clinical and molecular characteristics of a Brazilian family with spinocerebellar ataxia type 1 Características clínicas e moleculares de uma família Brasileira com ataxia espinocerebelar tipo 1
by: Iscia Lopes-Cendes, et al.
Published: (1996-09-01)